Linde plc (EU)

  • WKN: A2DSYC
  • ISIN: IE00BZ12WP82
  • Land: Irland

Nachricht vom 21.10.2021 | 12:00

Linde Starts Up Major New Hydrogen Facility in the U.S. Gulf Coast

DGAP-News: Linde plc / Key word(s): Miscellaneous
21.10.2021 / 12:00
The issuer is solely responsible for the content of this announcement.

Linde Starts Up Major New Hydrogen Facility in the U.S. Gulf Coast

Guildford, UK, October 21, 2021 - Linde (NYSE:LIN; FWB:LIN) announced today it has started up a new world-scale hydrogen production facility in Texas, bringing Linde's total U.S. Gulf Coast hydrogen capacity to approximately 1.5 billion cubic feet per day.

Linde's new plant has started supplying high-purity hydrogen to the Phillips 66 Sweeny Refinery in Old Ocean, Texas, under a long-term supply agreement. The new facility is located on Linde's approximately 600-kilometer U.S. Gulf Coast hydrogen pipeline, which runs from Lake Charles, Louisiana, to Freeport, Texas, and has now been extended to connect with the Sweeny Refinery. In addition to supplying Phillips 66, the new facility will meet the growing demand for hydrogen from other customers in the region.

"Over the past five years we have significantly expanded our already robust hydrogen supply system in the U.S. Gulf Coast," said Jeff Barnhard, Vice President South Region, Linde. "Supported by multiple supply sources and an innovative high-purity hydrogen storage cavern, this infrastructure enables us to provide our customers with reliable long-term supply. We are proud to have started up this major project on budget despite the macro challenges we encountered."

Linde is a global leader in the production, processing, storage and distribution of hydrogen. It has the largest liquid hydrogen capacity and distribution system in the world. The company operates the world's first high-purity hydrogen storage cavern plus pipeline networks totaling approximately 1,000 kilometers globally, to reliably supply its customers. Linde is at the forefront in the transition to clean hydrogen and has installed approximately 200 hydrogen fueling stations and 80 hydrogen electrolysis plants worldwide. The company offers the latest electrolysis technology through its world class engineering organization, key alliances and partnerships.

About Linde

Linde is a leading global industrial gases and engineering company with 2020 sales of $27 billion (€24 billion). We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain and protect our planet.

The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals. Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, hydrogen for clean fuels and much more. Linde also delivers state-of-the-art gas processing solutions to support customer expansion, efficiency improvements and emissions reductions.

For more information about the company and its products and services, please visit www.linde.com


Contacts:
 
Investor Relations
Juan Pelaez
Phone: +1 203 837 2213
Email: juan.pelaez@linde.com
Media Relations
Anna Davies
Phone: +44 1483 244705
Email: anna.davies@linde.com


21.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021